Menu
News
Ibogaine
Ketamine
LSD
MDMA
Psilocybin
Resources
Research Hubs
Studies and Reports
Provider Directory
Terminology
Opinion
Events
About Us
FDA
Lykos Therapeutics Slashes Workforce, Reshuffles Leadership After FDA Rejection
August
22
,
2024
Cybin Holds ‘Productive’ Meeting with FDA to Discuss Plans for CYB003
August
21
,
2024
MDMA for PTSD: Setback Sparks New Battle Plan
August
14
,
2024
NRx Pharmaceuticals to File Two New-Drug Applications in 2024
July
1
,
2024
Apex Labs Seeks FDA Approval for Study on Psilocybin Microdosing and Driver Safety
June
20
,
2024
Concerns Raised About MDMA-Assisted Psychotherapy Trials for PTSD
May
17
,
2024
1
2
3